News / Taiwan / economic_daily
Koming Revenue Grows 13.4% YTD, Prepares for IPO
Health Technology · Medical Specialties · economic_daily · 2026-11-09
Ophthalmology equipment manufacturer Koming reported a 13.38% year-to-date revenue increase and is moving forward with a capital increase ahead of its OTC listing.
What Happened
Revenue Performance: Koming reported October revenue of NT$53.91 million, a 3.06% increase year-on-year, with cumulative revenue for the first ten months reaching NT$636 million, up 13.38%. While monthly revenue saw a decline due to the deferral of large equipment installations, the overall growth trajectory remains solid.
Market Trends: Driven by an aging population and increased awareness of eye care, the penetration rate of self-paid intraocular lenses (IOLs) has reached 51%, surpassing those covered by national health insurance. Koming has successfully boosted its average selling price (ASP) by introducing high-end IOL products.
Capital Plans: The company's application for an OTC listing has been approved. Koming is currently conducting a cash capital increase of 2.525 million shares at a tentative price of NT$66 per share, aiming to raise NT$167 million. The filing is expected to become effective on November 12.
Future Outlook: Analysts remain optimistic about Koming's leadership in cataract surgery equipment and consumables. With the peak surgery season approaching, the company expects strong growth in consumable sales and aims to solidify its position as the top brand in the Taiwanese cataract surgery market.